Katsuaki Maehara/X
Apr 5, 2025, 11:52
Katsuaki Maehara: Key Insights from MRD Analysis of the ADAURA Trial
Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X:
“Osimertinib – MRD analysis of the ADAURA
The following slides summarize the key points of this paper. (IMO)”
More posts featuring Katsuaki Maehara.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 23, 2025, 07:22
Jun 23, 2025, 07:15
Jun 23, 2025, 07:10
Jun 23, 2025, 07:01
Jun 23, 2025, 06:51
Jun 23, 2025, 06:46